Skip to main content
. Author manuscript; available in PMC: 2016 Dec 10.
Published in final edited form as: Exp Cell Res. 2015 Nov 21;339(2):300–309. doi: 10.1016/j.yexcr.2015.11.021

Figure 7. CID-treated MΦ-cTLR4 Cells Activate the MyD88-independent Pathway.

Figure 7

Western Blot for p-IRF3 and total IRF3. Cells were lysed at timepoints indicated following CID drug (50 nM), LPS (100 ng/mL), or vehicle treatment. Top panel shows phosphorylated over total IRF3 ratio relative to the zero timepoint for each subsequent timepoint. Bottom panel shows corresponding blots.